Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to ...

"Because most people with obesity have elevated insulin levels, they develop insulin resistance, which contributes to weight gain. Semaglutide (or Ozempic) helps lower the levels of this fat-storing ...

Physicians Toxicology Laboratory had been accused of encouraging client healthcare practices to order drug tests for all patients regardless of medical need.

Less than 0.1% of adolescents in the United States identified as transgender or gender diverse and received puberty blockers ...

HealthDay News — Among privately insured US adolescents who identified as transgender and gender-diverse (TGD), receipt of puberty blockers and hormones was rare from 2018 to 2022, according to a ...

Premenstrual dysphoric disorder, or PMDD, can cause mood swings before your period. Doctors share remedies to treat the ...

US households with users of GLP-1 drugs like Ozempic spend 6-9% less on groceries, with ultra-processed foods seeing the ...

A study by Harvard Chan School researches shows puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse adolescents, countering concerns among ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse (TGD) adolescents, according to a new study from researchers at Harvard T.H. Chan School of ...

A new study found less than .1% of transgender and gender-diverse teens are prescribed puberty blockers or gender-affirming ...